Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Antiseptics Recalled Over Labeling Error
03/10/2022
First aid antiseptics used to help prevent infection of minor cuts, scrapes, and burns are under a Class II recall.
First aid antiseptics used to help prevent infection of minor cuts, scrapes, and burns are under a Class II recall.
First aid antiseptics used to...
03/10/2022
Pharmacy Learning Network
News
Methadone vs Buprenorphine for Reduced Overdose Risk, Treatment Retention
03/08/2022
Researchers found treatment with methadone or buprenorphine resulted in different overdose and retention outcomes among patients with opioid use disorder.
Researchers found treatment with methadone or buprenorphine resulted in different overdose and retention outcomes among patients with opioid use disorder.
Researchers found treatment with...
03/08/2022
Pharmacy Learning Network

Advertisement

News
Nasal Sprays Sold by Multiple Retailers Recalled
03/03/2022
A Class II recall has been issued for nasal sprays distributed by various retailers.
A Class II recall has been issued for nasal sprays distributed by various retailers.
A Class II recall has been...
03/03/2022
Pharmacy Learning Network
News
Antiseptic Products Recalled
03/03/2022
Antiseptic products used to prepare a patient’s skin prior to an injection or surgery are under a class II recall.
Antiseptic products used to prepare a patient’s skin prior to an injection or surgery are under a class II recall.
Antiseptic products used to...
03/03/2022
Pharmacy Learning Network
News
Subpotent Sanitizers Recalled
03/03/2022
Shuzy Rock Inc is voluntarily recalling hand sanitizers that were found to be subpotent for ethanol.
Shuzy Rock Inc is voluntarily recalling hand sanitizers that were found to be subpotent for ethanol.
Shuzy Rock Inc is voluntarily...
03/03/2022
Pharmacy Learning Network

Advertisement

News
From Alabama to Utah, Efforts to Vaccinate Medicaid Enrollees Against COVID-19 Run Into Obstacles
03/01/2022
According to data from several states, the rate of COVID-19 vaccinations among Medicaid enrollees continues to be lower than the general population.
According to data from several states, the rate of COVID-19 vaccinations among Medicaid enrollees continues to be lower than the general population.
According to data from several...
03/01/2022
Pharmacy Learning Network
News
Benzodiazepine Concentrate Recalled
02/24/2022
A prescription benzodiazepine is under a Class II recall for failing to meet impurity/degradation specifications.
A prescription benzodiazepine is under a Class II recall for failing to meet impurity/degradation specifications.
A prescription benzodiazepine is...
02/24/2022
Pharmacy Learning Network
News
Anxiety Medication Recalled
02/24/2022
ANI Pharmaceuticals is voluntarily recalling more than 500,000 bottles of a prescription used to treat patients with anxiety.
ANI Pharmaceuticals is voluntarily recalling more than 500,000 bottles of a prescription used to treat patients with anxiety.
ANI Pharmaceuticals is...
02/24/2022
Pharmacy Learning Network

Advertisement

News
Ophthalmic Solution Recalled
02/24/2022
A Class II recall has been issued for an antibiotic used to treat eye infections.
A Class II recall has been issued for an antibiotic used to treat eye infections.
A Class II recall has been...
02/24/2022
Pharmacy Learning Network
News
Cold Tablets Recalled
02/17/2022
Millions of cold tablets sold in bulk containers are under a Class II recall.
Millions of cold tablets sold in bulk containers are under a Class II recall.
Millions of cold tablets sold in...
02/17/2022
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use